Organon (OGN) Research & Development (2020 - 2026)

Organon's Research & Development history runs 7 years deep, the most recent figure standing at $93.0 million for Q1 2026.

• In Q1 2026, Research & Development fell 3.12% year-over-year to $93.0 million; the TTM figure through Mar 2026 stood at $363.0 million (down 15.97% YoY), while the FY2025 annual figure was $366.0 million, down 21.96% from the prior year.
• Research & Development was $93.0 million for Q1 2026 at Organon, up from $91.0 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $170.0 million in Q1 2024 to a low of $27.0 million in Q2 2022.
• Historically, Research & Development has averaged $110.9 million across 5 years, with a median of $116.0 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Research & Development sank 64.47% in 2022, then jumped 374.07% in 2023.
• A 5-year view of Research & Development shows it stood at $142.0 million in 2022, then dropped by 5.63% to $134.0 million in 2023, then declined by 2.99% to $130.0 million in 2024, then retreated by 30.0% to $91.0 million in 2025, then increased by 2.2% to $93.0 million in 2026.
• The last three Research & Development figures came in at $93.0 million (Q1 2026), $91.0 million (Q4 2025), and $84.0 million (Q3 2025), per Business Quant data.